Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Para-n-benzene - sulfoxy-n containing doai – and said benzene...
Reexamination Certificate
2006-07-04
2006-07-04
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Para-n-benzene - sulfoxy-n containing doai, and said benzene...
C514S316000, C544S180000, C544S194000, C544S238000, C544S092000, C544S284000, C544S287000, C546S152000, C546S179000, C546S193000, C546S201000
Reexamination Certificate
active
07071177
ABSTRACT:
This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
REFERENCES:
patent: 3615606 (1971-10-01), Schulte et al.
patent: 4277492 (1981-07-01), Daniel et al.
patent: 4857530 (1989-08-01), Berman et al.
patent: 4987023 (1991-01-01), Sato et al.
patent: 5538976 (1996-07-01), Okada et al.
patent: 5952349 (1999-09-01), Asberom et al.
patent: 0 757 037 (1997-02-01), None
patent: WO 98/01425 (1998-01-01), None
patent: WO 98/01425 (1998-01-01), None
patent: WO 9801425 (1998-01-01), None
patent: WO 98/25893 (1998-06-01), None
patent: WO 98/50029 (1998-11-01), None
patent: WO9850023 (1998-11-01), None
patent: WO 01/17982 (2001-03-01), None
CAS printout for Sebti, Chem. Abs. 130: 25338.
CAS printout for Hirsch et al, Chem. Abs. 86: 197939.
CAS printout for Okada et al. 127:242825.
CAS printout for Barton et al.
CAS printout for Mattor et al.
CAS printout for Asberrom et al. Chem. Abs. 131:214192.
CAS printout for Dinsmore et al. Chem. Abs. 132: 160824.
CAS printout for Sebti et al. Chem. Abs. 130: 25338.
CAS printout for Okada et al. Chem. Abs. 127;242825.
Balinska et al. “Effect of Combined Inhibitors of Thymidylate Synthase ... ”, Anticancer Research 17: 4519-4524 (1997).
Balinska et al. “The effects of combined antifolates on inhibition of growth of murine leukemia cells curtured in vitro”, Acta Biochmica Polonica vol. 44, No. Apr. 1997, p. 743-750.
Okada et al. “Studies on Aromatase Inhibitiors IV ... ”, Chem. Pharm. Bull. 45(8) 1293-1299 (1997).
Jones et al., “Structure based Design of Lipophilic Quinazoline Inhibitors of Thymidylate Synthase”, J. Med. Chem. 1996, 39, 904-917.
Dinsmore et al., “Imidazole-Containing Diarylether and diarylsulfone inhibitors of farnesyl-protein transferase”, Bioorganic & Medicinal Chemistry Letters 9 (1999) 3301-3306.
Barton, et al., “The Invention of Radical Reactions. 30. Diazirines as Carbon Radical Traps. Mechanistic Aspects and Synthetic Applications of a Novel and Efficient Amination Process”,J. American Chemical Soc., (1993) pp 8050-8059, vol. 115.
McNamara, et al., “Potent Inhibition of Thymidylate Synthase by Two Series of Nonclassical Quinazolines”,J. Med. Chem., (1990) pp 2045-2051, vol. 33.
Jones, et al., “Structure-Based Design of Lipophilic Quinazoline Inhibitors of Thymidylate Synthase”,J. Med. Chem., (1996) pp 904-917, vol. 39.
Chemical Abstracts, No. 86:155606 (1977), p. 469, vol. 86 Djudovic, et al., “Synthesis of quinoline-3- and quinoxaline-2 derivatives and their effect against various malarial causative organisms”, Pharmazie (1976), pp 845-849, vol. 31:12.
Chemical Abstracts, No. 84:30945 (1976), p. 452, vol. 84 Kutla, “Condensation products of saccharin with some amines”, Istanbul University Eczacilik Fak. Mecm., (1975), pp 5-7, vol. 11:1.
Dinsmore, et al., “Imidazole-Containing Diarylether and Diarysulfone Inhibitors of Farnesyl-Protein Transferase,”Bioorganic&Medicinal Chemistry Letters, (1999) pp 3301-3306, vol. 9:23.
Desai, et al., “Studies in Sulphanilamide and Allied Compounds,”Indian J. Pharm., (1951) pp 211-213, No. 13, XP-000926589.
Billman, et al., “The Reductive Acylation of Schiff Bases Using Trimethylamine Borane,”J. Org. Chem., (1962) pp 2640-2643, vol. 27, XP-001015561.
Katritzky, et al., “A Novel Method for the Preparation of 3-Amino-4-Hydroxybenzenefulfonamide Precursors of “Acid Alizarin Violet N” Derivatives,” (1993)Synth. Commun., pp 405-417, vol. 23:3 XP-000926588.
Krauss Nancy Elisabeth
Mirzadegan Taraneh
Smith David Bernard
Walker Keith Adrian
Green Grant D.
Syntex (U.S.A.) LLC
Ward Paul V.
Wilson James O.
LandOfFree
P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3613853